1. 2009
  2. Chemorepulsive semaphorins

    Verhaagen, J. (Speaker)
    16 Jan 2009

    Activity: Talk or presentationAcademic

  3. Genomics, cellomics and viral vector mediated gene transfer.

    Verhaagen, J. (Speaker)
    19 Jan 2009

    Activity: Talk or presentationAcademic

  4. A role for the chemorepulsive protein semaphorin3A in the pathogenesis of ALS?

    Verhaagen, J. (Speaker)
    13 Feb 2009

    Activity: Talk or presentationAcademic

  5. Is semaphorin3A-Neuropilin1 signaling involved in the pathogenesis of ALS?

    Verhaagen, J. (Speaker)
    03 Apr 2009

    Activity: Talk or presentationAcademic

  6. Gene therapy to treat neurodegenerative diseases.

    Verhaagen, J. (Speaker)
    07 Apr 2009

    Activity: Talk or presentationAcademic

  7. Developing restorative treatments for neurodegenerative diseases: dream or future?

    Verhaagen, J. (Speaker)
    17 Jul 2009

    Activity: Talk or presentationAcademic

  8. Viral vectors: basic science and therapeutic applications.

    Verhaagen, J. (Speaker)
    28 Aug 2009

    Activity: Talk or presentationAcademic

  9. Viral vectors: basic science and therapeutic applications.

    Verhaagen, J. (Speaker)
    09 Sep 2009

    Activity: Talk or presentationAcademic

  10. Developing restorative treatments for neurodegenerative disease.

    Verhaagen, J. (Speaker)
    23 Oct 2009

    Activity: Talk or presentationAcademic

  11. Repairing the injured brain or spinal cord by gene therapy.

    Verhaagen, J. (Speaker)
    02 Nov 2009

    Activity: Talk or presentationAcademic

Previous 1 2 3 Next

ID: 13176